Several over-the-counter eye care products have been recalled across the nation due to potential quality concerns. This voluntary recall was initiated by BRS Analytical Service, LLC, following an inspection by the U.S. Food and Drug Administration (FDA).
A notification from medical distributor AvKARE indicates that while the specific health risks associated with these products remain unclear, deviations observed during the FDA audit suggest that certain items may not meet acceptable quality standards. This raises concerns that their use could pose risks to patients.
The products involved in the recall include:
– Artificial Tears Ophthalmic Solution
– Carboxymethylcellulose Sodium Ophthalmic Gel 1%
– Carboxymethylcellulose Sodium Ophthalmic Solution
– Lubricant Eye Drops Solution
– Polyvinyl Alcohol Ophthalmic Solution
These products were initially shipped from May 26, 2023, and are expected to be on the market until April 21, 2025. AvKARE is advising retailers to promptly check their inventory for these recalled items, halt their use, and remove them from sale.
For those looking for comprehensive details, including lot numbers affected by the recall, AvKARE has provided resources for returning the recalled products.
This recall emphasizes the importance of quality control in medical products and the proactive measures organizations take to safeguard consumer health. It is a reminder for consumers to stay informed about the products they use and to follow up on recalls or safety alerts issued by health authorities.